IGHE and allergic disease: Finally, we interrogated systemic immunological and allergy markers, including basophil activation, and the effect of intra‐patient dose escalation from 6 mg to 12 mg in Patient A, to understand if any of these parameters are associated with the urticarial reactions in MOv18 IgE‐treated patients.